| Identification | Back Directory | [Name]
2,4-DICHLORO-7-BROMOQUINAZOLINE | [CAS]
959237-68-4 | [Synonyms]
2,4-DICHLORO-7-BROMOQUINAZOLINE
7-Bromo-2,4-dichloroquinazoline
Quinazoline, 7-bromo-2,4-dichloro- | [Molecular Formula]
C8H3BrCl2N2 | [MDL Number]
MFCD09954890 | [MOL File]
959237-68-4.mol | [Molecular Weight]
277.94 |
| Chemical Properties | Back Directory | [Boiling point ]
330.2±24.0 °C(Predicted) | [density ]
1.851±0.06 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2-8°C | [pka]
-1.17±0.30(Predicted) | [Appearance]
White to yellow Solid |
| Hazard Information | Back Directory | [Synthesis]
The general procedure for the synthesis of 2,4-dichloro-7-bromoquinazoline from 7-bromoquinazoline-2,4(1H,3H)-dione was as follows: 205.0 g (0.84 mol) of 7-bromo-1H-benzo[d]-1,3-oxazine-2,4-dione was suspended in 1.26 L (12.59 mol) of phosphorochloride at room temperature, followed by the addition of 71.34 mL (0.42 mol) N-ethyl diisopropylamine. The reaction mixture was heated to reflux and kept for 36 hours. Upon completion of the reaction, 193.6 g of the target product 7-bromo-2,4-dichloroquinazoline was obtained by a conventional post-processing step. The product was analyzed by HPLC/MS and showed that the (M+H)+ peak was located at 277/279, confirming the solid form. | [References]
[1] Patent: US2013/12489, 2013, A1. Location in patent: Paragraph 0174
[2] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 21, p. 4904 - 4907
[3] Patent: WO2012/58671, 2012, A1. Location in patent: Page/Page column 92-93
[4] Patent: US2014/38952, 2014, A1. Location in patent: Page/Page column 0160-0161
[5] Antimicrobial Agents and Chemotherapy, 2017, vol. 61, # 6, |
|
|